Drug related problems after discharge from an Australian teaching hospital

被引:48
作者
Ellitt, Glena R. [1 ]
Engblom, Ellinor [2 ]
Aslani, Parisa [1 ]
Westerlund, Tommy [2 ,3 ,4 ]
Chen, Timothy F. [1 ]
机构
[1] Univ Sydney, Fac Pharm A15, Sydney, NSW 2006, Australia
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med,Unit Social Med, Gothenburg, Sweden
[3] Apoteket AB, Res & Dev, Helsingborg, Sweden
[4] Apoteket AB, Res & Dev, Stockholm, Sweden
来源
PHARMACY WORLD & SCIENCE | 2010年 / 32卷 / 05期
关键词
Australia; Cardiovascular; Continuity of care; Drug related problems; Medication reconciliation; Medication review; PHARMACY-BASED PROVISION; PHARMACEUTICAL CARE; COMMUNITY PHARMACISTS; MEDICATION; INTERVENTION; HYPERTENSION; PREVENTION; ADHERENCE; REVIEWS; DISEASE;
D O I
10.1007/s11096-010-9406-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective To reconcile patients' medicines and to classify drug related problems identified during medication review conducted after discharge from hospital. Setting Patients were discharged from the cardiology unit of Westmead Hospital after recruitment into the Westmead Medicines Project which ran from 2004 to 2007. Method This retrospective study involved an analysis of drugs, diseases and drug related problems in medication review reports available for 76 out of 85 patients who received a Home Medicines Review (HMR). Data sources for medication reconciliation and analyses also included hospital discharge summaries (n = 70) and GP referrals for HMR (n = 44). Comprehensive clinical profiles were constructed for the 76 subjects whose drug related problems were identified, coded, and then classified from their HMR reports. Main outcome measures Number, type, distribution and international classification of drugs, diseases and drug-related problems. Results Patients were prescribed drugs for a broad range of cardiovascular, circulatory, endocrine, respiratory and digestive system diseases. Mean number of drugs per patient in discharge summaries: 8.7 +/- SD 3.3 (range 3-19); in GP referrals: 8.9 +/- SD 4.3 (range 2-23); and in HMR reports: 10.8 +/- SD 4.0 (range 3-24). Mean number of diseases per patient in discharge summaries: 4.1 +/- SD 2.9 (range 1-11); and in HMR reports: 4.7 +/- SD 2.6 (range 1-12). A total of 398 drug related problems were identified for 71 (93.3%) patients with mean 5.6 +/- SD 4.3 problems (range 1-21). The most frequently recorded problems were the patients' uncertainty about drug aim: n = 128 (32.0%); potential interactions n = 89 (22.4%); and adverse reactions n = 60 (15.1%). Conclusion This study showed that patients recently discharged from a tertiary care hospital had a significant number of drug related problems. Classification of drugs and diseases revealed a broad range of non-cardiovascular medicines and conditions in the patients from an acute care cardiology unit. We found that home medicines review provided continuity of care and an opportunity for medication reconciliation which revealed marked differences in number of drugs, between hospital discharge and medicines review. The patients' uncertainly about their drugs and their diverse range of co-morbidities indicated the need for timely counselling by pharmacists in the community.
引用
收藏
页码:622 / 630
页数:9
相关论文
共 35 条
  • [1] Keeping your patient with heart failure safe - A review of potentially dangerous medications
    Amabile, CM
    Spencer, AP
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (07) : 709 - 720
  • [2] *AUSTR GOV MED AUS, 2009, HOM MED REV HMR
  • [3] Drug-related problems in the community setting - Pharmacists' findings and recommendations for people with mental illnesses
    Bell, J. Simon
    Whitehead, Paula
    Aslani, Parisa
    McLachlan, Andrew J.
    Chen, Timothy F.
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (07) : 415 - 425
  • [4] Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care -: A multicentre study in seven European countries
    Bernsten, C
    Björkman, I
    Caramona, M
    Crealey, G
    Frokjær, B
    Grundberger, E
    Gustafsson, T
    Henman, M
    Herborg, H
    Hughes, C
    McElnay, J
    Magner, M
    van Mil, F
    Schaeffer, M
    Silva, S
    Sondergaard, B
    Sturgess, I
    Tromp, D
    Vivero, L
    Winterstein, A
    [J]. DRUGS & AGING, 2001, 18 (01) : 63 - 77
  • [5] Pharmacist intervention program for control of hypertension
    Chabot, I
    Moisan, J
    Grégoire, JP
    Milot, A
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) : 1186 - 1193
  • [6] CHEN TF, 2009, HOSP COMMUNITY MULTI
  • [7] Quality of care in stroke prevention: results of an audit study among general practitioners
    de Koning, JS
    Klazinga, NS
    Koudstaal, PJ
    Prins, A
    Dippel, DWJ
    Heeringa, J
    Kleyweg, RP
    Neven, AK
    Van Ree, JW
    Rinkel, GJE
    Mackenbach, JP
    [J]. PREVENTIVE MEDICINE, 2004, 38 (02) : 129 - 136
  • [8] Building bridges - A partnership between professional nursing and the centers for disease control and prevention to reduce the burden of heart disease and stroke
    Dunbar, SB
    Mensah, GA
    Labarthe, DR
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2005, 29 (05) : 122 - 127
  • [9] Quality Patient Care and Pharmacists' Role in Its Continuity-A Systematic Review
    Ellitt, Glena R.
    Brien, Jo-anne E.
    Aslani, Parisa
    Chen, Timothy F.
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (04) : 677 - 691
  • [10] Emblen Graham, 2004, Aust Fam Physician, V33, P49